Align Technology Shares Outstanding 2006-2018 | ALGN

Align Technology shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Align Technology shares outstanding for the quarter ending September 30, 2018 were 0.081B, a 0.53% decline year-over-year.
  • Align Technology 2017 shares outstanding were 0.082B, a 0.43% increase from 2016.
  • Align Technology 2016 shares outstanding were 0.081B, a 0.05% decline from 2015.
  • Align Technology 2015 shares outstanding were 0.082B, a 0.93% decline from 2014.
Align Technology Annual Shares Outstanding
(Millions of Shares)
2017 82
2016 81
2015 82
2014 82
2013 83
2012 83
2011 80
2010 78
2009 69
2008 68
2007 71
2006 63
2005 63
Align Technology Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 81
Q2 2018 81
Q1 2018 82
Q4 2017 82
Q3 2017 82
Q2 2017 82
Q1 2017 82
Q4 2016 81
Q3 2016 81
Q2 2016 81
Q1 2016 81
Q4 2015 82
Q3 2015 81
Q2 2015 81
Q1 2015 82
Q4 2014 82
Q3 2014 82
Q2 2014 82
Q1 2014 83
Q4 2013 83
Q3 2013 82
Q2 2013 82
Q1 2013 81
Q4 2012 83
Q3 2012 81
Q2 2012 83
Q1 2012 82
Q4 2011 80
Q3 2011 80
Q2 2011 80
Q1 2011 79
Q4 2010 78
Q3 2010 78
Q2 2010 78
Q1 2010 78
Q4 2009 69
Q3 2009 70
Q2 2009 67
Q1 2009 66
Q4 2008 68
Q3 2008 69
Q2 2008 70
Q1 2008 71
Q4 2007 71
Q3 2007 72
Q2 2007 71
Q1 2007 69
Q4 2006 63
Q3 2006 63
Q2 2006 63
Q1 2006 63
Q4 2005 63
Q3 2005 62
Q2 2005 63
Q1 2005 63
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $17.380B $1.473B
Align Technology, Inc. is a global medical device company with industry-leading innovative products such as Invisalign clear aligners, iTero Intraoral scanners, and OrthoCAD digital services that help dental professionals achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $63.204B 21.53
McKesson (MCK) United States $25.491B 9.74
AmerisourceBergen (ABC) United States $19.455B 13.88
Laboratory Of America Holdings (LH) United States $16.901B 15.30
Cardinal Health (CAH) United States $16.664B 11.19
Henry Schein (HSIC) United States $12.934B 21.27
Cooper (COO) United States $12.862B 23.16
DENTSPLY SIRONA (XRAY) United States $8.132B 16.24
West Pharmaceutical Services (WST) United States $7.919B 39.30
Merit Medical Systems (MMSI) United States $3.171B 37.62
Patterson (PDCO) United States $2.306B 16.21
CONMED (CNMD) United States $1.925B 31.98
STAAR Surgical (STAA) United States $1.900B 195.68
Atrion (ATRI) United States $1.328B 37.98
Antares Pharma (ATRS) United States $0.529B 0.00
Invacare (IVC) United States $0.236B 0.00
Lifevantage (LFVN) United States $0.168B 23.78
Endologix (ELGX) United States $0.106B 0.00
Aceto (ACET) United States $0.053B 0.00
Pro-Dex (PDEX) United States $0.053B 23.68
Biolase (BIOL) United States $0.031B 0.00
Retractable Technologies (RVP) United States $0.022B 0.00
Milestone Scientific (MLSS) United States $0.020B 0.00